Ortho Diagnostic Systems

Ortho Clinical Diagnostics is a leading global provider of in vitro diagnostics, serving the clinical laboratory and transfusion medicine communities. The company develops and manufactures sophisticated instrument systems and reagents for clinical chemistry, immunoassay, and blood typing. Its core technology, the VITROS platform, utilizes dry-slide technology to reduce the need for water and plumbing in labs while providing high-accuracy results. Ortho is particularly well-known for its leadership in blood banking, providing critical screening tools for the world's blood supply. In 2022, the company was acquired by Quidel Corporation to form QuidelOrtho, creating a comprehensive diagnostics powerhouse. The combined entity spans the full spectrum of testing from point-of-care settings to high-throughput clinical laboratories.